Cargando…
The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study
BACKGROUND: Immunotherapeutic treatments targeting amyloid-β plaques in Alzheimer’s disease (AD) are associated with the presence of amyloid-related imaging abnormalities with oedema or effusion (ARIA-E), whose detection and classification is crucial to evaluate subjects enrolled in clinical trials....
Autores principales: | Martens, Roland M., Bechten, Arianne, Ingala, Silvia, van Schijndel, Ronald A., Machado, Vania B., de Jong, Marcus C., Sanchez, Esther, Purcell, Derk, Arrighi, Michael H., Brashear, Robert H., Wattjes, Mike P., Barkhof, Frederik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811582/ https://www.ncbi.nlm.nih.gov/pubmed/28956123 http://dx.doi.org/10.1007/s00330-017-5022-6 |
Ejemplares similares
-
Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer’s disease
por: Ingala, Silvia, et al.
Publicado: (2022) -
Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla
por: Simon, Birgit, et al.
Publicado: (2010) -
Visual assessment of posterior atrophy development of a MRI rating scale
por: Koedam, Esther L. G. E., et al.
Publicado: (2011) -
Making better use of our brain MRI research data
por: Barkhof, Frederik
Publicado: (2012) -
Accelerating regional atrophy rates in the progression from normal aging to Alzheimer’s disease
por: Sluimer, Jasper D., et al.
Publicado: (2009)